⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1663298 | 0.80 | PPM1B (0.37) | — | |
| SCHEMBL42660 | 0.78 | MEN1 (0.38) | — | |
| SCHEMBL5135807 | 0.70 | — | — | |
| SCHEMBL14630769 | 0.70 | — | — | |
| SCHEMBL1583863 | 0.70 | — | — | |
| SCHEMBL14630771 | 0.70 | — | — | |
| SCHEMBL5135804 | 0.70 | — | — | |
| SCHEMBL1583972 | 0.70 | — | — | |
| SCHEMBL2685140 | 0.70 | — | — | |
| SCHEMBL1584181 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970257-B1 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | ABBVIE INC (US) | 2018-05-30 | — | — | EP | disclosed |